NC
TMO icon

North Capital’s Thermo Fisher Scientific TMO Stock Holding History

North Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-243
Closed -$118K – 635
2025
Q3 		$118K Sell
243
-2
-0.8% -$931 0.09% 132
2025
Q2 		$99.3K Sell
245
-2
-0.8% -$836 0.09% 139
2025
Q1 		$123K Buy
+247
New +$134K 0.12% 113

Other funds holding TMO

JSC
J. Stern & Co London, United Kingdom $1.06B AUM 11.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

North Capital's TMO Position: Q4 2025 in Review

North Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2025, closing a stake of 243 shares — an estimated $118K sold.

North Capital first reported a position in TMO in Q1 2025 and held it in 3 quarters. The position peaked at $123K in Q1 2025. 2,701 funds tracked by Wall St. Rank hold TMO as of Q4 2025.

  • North Capital reported no remaining Thermo Fisher Scientific position as of Q4 2025 after selling out during the quarter.
  • North Capital sold 243 Thermo Fisher Scientific shares in Q4 2025, an estimated $118K.
  • North Capital first reported a position in Thermo Fisher Scientific in Q1 2025 and held it in 3 quarters.
  • North Capital's Thermo Fisher Scientific position peaked at $123K in Q1 2025.
  • 2,701 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2025.

Based on North Capital's 13F filing for Q4 2025, filed 18 Feb 2026.